Endomedix, Inc.
PlexiClot stops bleeding via patented action in brain & spine surgery, a high value $1.9B market, positioning Endomedix for an early exit.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Montclair, NJ, US
- Currency USD
- Founded July 2014
- Employees 3
- Incorporation Type C-corp
- Website endomedix.com
Company Summary
Endomedix is a Delaware C corp. located in Montclair, NJ. It has developed PlexiClot™ Absorbable Hemostat to control bleeding in brain & spine surgery, a $1.9B market. Led by a MedTech veteran of 2 prior start-ups with exits and a renown scientific team, Endomedix will win FDA’s 1st specific approval for a hemostat in brain surgery. The Company is driving toward an early exit prior to final FDA approval.
Team
-
CEO
35+ years in history. Veteran of 2 early stage MedTech ventures w/successful exits. Hands-on leader with strong general management, sales & marketing, international, new products clinical trial and regulatory affairs experience. Successfully obtained 2 FDA PMA & 1 CE mark approvals. Lead cash investor in Endomedix.
-
Vice President - Research & Development
Solid development experience, led creation of new patented chemistry. Developed breakthrough techniques for biopolymer processing. Lead inventor on patents & author of ground breaking scientific publications. Effective at leading & coordinating world class team of subject matter experts in fields of biopolymer design, chemical engineering, chemometrics.
-
Michael Jaffe, PhDPolymer Chemistry Research
World renown polymer expert. Past chair, Polymeric Materials, Science & Engineering Division of American Chemical Society; Editor of "Polymers for Advanced Technologies, 1989-2001. Thomas Alva Edison Patent Award - 1995, 2011; North American Thermal Analysis Society Lifetime Achievement Award - 2010; Fellow-American Association for the Advancement of Science - 1993
-
Organic Chemistry Scientist
Allied Signal Inc. -Research, Advanced Molecular Modeling and Computational Chemistry Applications; Group Leader-Nuclear Magnetic Resonance; High Performance Computing.
Hoechst Research and Technology-Scientist, NMR Spectroscopy
Yale University, Department of Chemistry-Assistant Professor of Chemistry
BA, Chemistry-Northwestern University; PhD & MS-Organic Chemistry-Columbia University; NIH Post Doctoral Fellow-California Institute of Technology. -
Thomas Gsell, PhDChemical Engineering
Ret: Sr Corp VP-R&D, Pall Corporation. Key member of Pall Medical Business Unit launched platform of successful blood filtration products aimed at removing white blood cells from transfused blood. Co-inventor on 100+ issued and Published US and International patents, as well as a number of peer-reviewed scientific publications.
BS Chemistry-SUNY Albany; MS Polymer Chemistry-Florida State University; PhD Polymer Sciences - Polytechnic University.
Advisors
-
William Cobb MD, PhDUnconfirmedNeil R. Malhotra, MDUnconfirmedAnthony D' Ambrosio, MDUnconfirmed
-
Rupa Juthani, MDUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.